Inventor · disambiguated record
Shin'Ichi Takeda
Also filed as: TAKEDA SHIN ICHI · TAKEDA SHINICHI
27 granted patents·19 pending applications·446 citations·filing 2010–2024
97Inventor score
Files withNIPPON SHINYAKU CO LTD38NAT CENTER NEUROLOGY & PSYCHIATRY4OKADA TAKASHI1TAKEDA SHIN ICHI1URADE YOSHIHIRO1
Top patents by PatentIndex Score
46 records- 0198US11028122B1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2021·Granted Jun 8, 2021·14 cites·5 claims
- 0298US10662217B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted May 26, 2020·15 cites·4 claims
- 0398US10487106B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Nov 26, 2019·33 cites·2 claims
- 0498US10407461B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Sep 10, 2019·33 cites·2 claims
- 0598US10385092B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Aug 20, 2019·39 cites·3 claims
- 0698US10329319B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2017·Granted Jun 25, 2019·14 cites·7 claims
- 0798US9708361B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2015·Granted Jul 18, 2017·38 cites·7 claims
- 0898US9079934B2Antisense nucleic acidsWATANABE NAOKI·Filed 2011·Granted Jul 14, 2015·53 cites·7 claims
- 0997US9840706B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2015·Granted Dec 12, 2017·41 cites·12 claims
- 1096US10781448B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2018·Granted Sep 22, 2020·14 cites·13 claims
- 1196US9988629B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2015·Granted Jun 5, 2018·39 cites·10 claims
- 1296US9512424B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2012·Granted Dec 6, 2016·37 cites·9 claims
- 1395US10683322B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Jun 16, 2020·4 cites·10 claims
- 1495US10144931B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2016·Granted Dec 4, 2018·35 cites·19 claims
- 1595US9890381B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2016·Granted Feb 13, 2018·15 cites·9 claims
- 1694US10870676B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Dec 22, 2020·3 cites·18 claims
- 1793US2025042933A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2024·Application pending·0 cites
- 1892US10647741B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted May 12, 2020·2 cites·12 claims
- 1990US11053497B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2019·Granted Jul 6, 2021·3 cites·9 claims
- 2089US2025188459A1Antisense Nucleic AcidsNIPPON SHINYAKU CO LTD·Filed 2024·Application pending·0 cites
- 2188US11193125B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2017·Granted Dec 7, 2021·3 cites·18 claims
- 2288US10851373B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2018·Granted Dec 1, 2020·4 cites·20 claims
- 2388US2025145997A1Antisense Nucleic AcidsNIPPON SHINYAKU CO LTD·Filed 2024·Application pending·0 cites
- 2487US2023151050A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2022·Application pending·0 cites
- 2586US11655472B2Antisense nucleic acid that induces skipping of exon 50NIPPON SHINYAKU CO LTD·Filed 2022·Granted May 23, 2023·1 cites·17 claims
- 2685US11781140B2Antisense nucleic acid inducing skipping of exon 51NIPPON SHINYAKU CO LTD·Filed 2022·Granted Oct 10, 2023·1 cites·19 claims
- 2784US11981894B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2020·Granted May 14, 2024·1 cites·24 claims
- 2883US2024368597A1Antisense Nucleic AcidsNIPPON SHINYAKU CO LTD·Filed 2024·Application pending·0 cites
- 2982US2025084412A1Antisense Nucleic AcidsNIPPON SHINYAKU CO LTD·Filed 2024·Application pending·0 cites
- 3081US2021340171A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2021·Application pending·0 cites
- 3180US2021284680A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2021·Application pending·0 cites
- 3279US2021179659A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2020·Application pending·0 cites
- 3378US11191733B2Drug delivery particle and method for producing the sameNAT CENTER NEUROLOGY & PSYCHIATRY·Filed 2017·Granted Dec 7, 2021·1 cites·4 claims
- 3477US9610354B2Drug delivery particle and method for producing the sameOKADA TAKASHI·Filed 2012·Granted Apr 4, 2017·3 cites·7 claims
- 3576US12060556B2Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2021·Granted Aug 13, 2024·0 cites·13 claims
- 3674US2022162604A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2021·Application pending·0 cites
- 3772US2021222169A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2020·Application pending·0 cites
- 3868US2022047521A1Drug Delivery Particle and Method for Producing the SameNAT CENTER NEUROLOGY & PSYCHIATRY·Filed 2021·Application pending·0 cites
- 3960US2018179538A1Antisense nucleic acidsNIPPON SHINYAKU CO LTD·Filed 2018·Application pending·0 cites
- 4058US2023073008A1Antisense nucleic acid that induces skipping of exon 50NIPPON SHINYAKU CO LTD·Filed 2020·Application pending·0 cites
- 4157US2023140736A1Antisense nucleic acid inducing skipping of exon 51NIPPON SHINYAKU CO LTD·Filed 2021·Application pending·0 cites
- 4256US2023045557A1Antisense nucleic acid enabling exon skippingNIPPON SHINYAKU CO LTD·Filed 2020·Application pending·0 cites
- 4349US2022127606A1Nucleic acid delivery complexNAT CENTER NEUROLOGY & PSYCHIATRY·Filed 2020·Application pending·0 cites
- 4445US2022144902A1Method for inducing muscular cells using cells in spot urineNAT CENTER NEUROLOGY & PSYCHIATRY·Filed 2018·Application pending·0 cites
- 4544US2012329046A1Molecular marker for evaluating pathological conditions and treatment of muscular dystrophyTAKEDA SHIN ICHI·Filed 2012·Application pending·0 cites
- 4640US8658390B2Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseasesURADE YOSHIHIRO·Filed 2010·Granted Feb 25, 2014·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Shin'Ichi Takeda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →